LATEST NEWS FROM PCDE AND ITS PARTNERS

News from partners: Enriched treatment Pathway T2DM

News from partners: Enriched treatment Pathway T2DM

Free access to an expert-led, practical and evidence-based tool designed to help you to provide optimal management of type 2 diabetes with glucagon-like peptide-1 receptor agonists (GLP-1RAs). Guided by internationally renowned diabetes researcher Professor Melanie...

read more
ANNOUNCEMENT – WINNERS PCDE RESEARCH GRANT 2021

ANNOUNCEMENT – WINNERS PCDE RESEARCH GRANT 2021

Each year PCDE issues a research grant for research projects in Primary Care. The submissions were competitive this year and each of them would have been a worthy winner. The PCDE board would like to thank everyone who submitted a proposal, for their contribution...

read more
NEWS FROM PARTNERS: EURADIA

NEWS FROM PARTNERS: EURADIA

EURADIA is undertaking a survey to highlight the impact of the Covid-19 pandemic on research funding. There is already evidence of Diabetes research being impacted - despite an increased threat to health from Covid-19 for people with Diabetes. We are looking for...

read more
PCDE’s latest publication

PCDE’s latest publication

Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin–angiotensin–aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.Samuel...

read more
EUDF-EASD symposium on 29 September

EUDF-EASD symposium on 29 September

IT TAKES MORE THAN JUST A REGISTRY TO IMPROVE CARE:   HOW CAN WE USE DATA TO RAISE AWARENESS AND INITIATE ACTION TO IMPROVE OUTCOMES FOR PEOPLE WITH DIABETES? Welcome and introduction David Matthews, University of Oxford, vice-chair EUDF How can we use data to raise...

read more

UPCOMING EVENTS

  • No events